T Helper 1 Cellular Immunity Toward Recoverin Is Enhanced in Patients With Active Autoimmune Retinopathy.

Area of Science:

• Ophthalmology
• Immunology
• Retinal Degeneration

Background:

• Autoimmune retinopathy (AIR) causes rapid vision loss, often misdiagnosed as retinitis pigmentosa (RP).
• Current diagnostic assays for AIR, like anti-retinal antibody (ARA) Western blots, may not reflect active disease.
• Identifying specific immune biomarkers is crucial for accurate AIR diagnosis and monitoring.

Purpose of the Study:

• To compare immune biomarkers and cellular responses to the retinal protein recoverin in newly diagnosed AIR patients, RP patients, and healthy controls.
• To investigate potential diagnostic indicators beyond current serological tests.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure anti-recoverin IgG and IgM antibodies.
• Cellular immune responses (IFNγ, IL-10) to recoverin were assessed.
• Flow cytometry analyzed peripheral blood mononuclear cells (PBMCs), including CD4+ T helper (TH) cells.
• Messenger RNA (mRNA) expression of immune-related genes was compared between groups.

Main Results:

• All participants had measurable anti-recoverin antibodies; AIR patients showed elevated anti-recoverin IgG1 levels.
• AIR patients exhibited a strong cellular response to recoverin, dominated by interferon-gamma (IFNγ) production.
• Both AIR and RP patients had reduced CD4+ TH cell counts.
• Gene expression analysis revealed distinct patterns in AIR patients, including altered expression of ATG5, PTPN22, and genes related to T cell signaling.

Conclusions:

• An immune response to recoverin is a normal human phenomenon.
• AIR patients display a significantly shifted immune response towards recoverin, characterized by heightened IFNγ production and cellular activation.
• These findings highlight specific immune signatures that may aid in differentiating AIR from RP and other retinal degenerations.